Treatment of multifocal motor neuropathy

Neurological Sciences

Volumn 24, Issue SUPPL. 4, 2003, Pages

  Nobile Orazio, E ^a   Terenghi, F ^a   Carpo, M ^a   Bersano, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Conduction block; Gangliosides; IVIg therapy; Neuropathy

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CYCLOPHOSPHAMIDE; GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ACUTE KIDNEY FAILURE; ARTICLE; ASEPTIC MENINGITIS; BLOOD CLOTTING DISORDER; CHILL; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG MEGADOSE; ELECTRODIAGNOSIS; FEVER; FLUSHING; HEADACHE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; LOW DRUG DOSE; MALAISE; MOTOR NERVE BLOCK; MOTOR NERVE CONDUCTION; MOTOR NEUROPATHY; NEUTROPENIA; PLASMAPHERESIS; PRURITUS; RASH; THROMBOEMBOLISM;

AUTOANTIBODIES; GANGLIOSIDES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MOTOR NEURON DISEASE; PLASMA EXCHANGE;

EID: 0142217507     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-003-0089-z     Document Type: Article

References (27)

1. Pestronk A, Cornblath DR, Ilyas A, Baba H, Quarles RH, Griffin JW, Alderson K, Adams RN (1988) A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24:73-78
2. Nobile-Orazio E (2001) Multifocal motor neuropathy. J Neuroimmunol 115:4-18
3. Olney RK, Lewis RA, Putnam TD, Campellone JV (2003) Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27:117-121
4. Olney RK (1999) Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 22[Suppl 8]:S225-S229
5. Nobile-Orazio E, Meucci N, Carpo M, Terenghi F, Bersano A, Cappellari A, Barbieri S, Scarlato G (2002) Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block. J Neurol Neurosurg Psychiatry 72:72:761-766
6. Katz JS, Wolfe GI, Bryan WW, Jackson CE, Amato AA, Barohn RJ (1997) Electrophysiologic findings in multifocal motor neuropathy. Neurology 48:700-707
7. Pakiam ASI, Parry GJ (1998) Multifocal motor neuropathy without overt conduction block. Muscle Nerve 21:243-245
8. Katz JS, Barohn RJ, Kojan S, Wolf GI, Natioons SP, Saperstein DS, Amato AA (2002) Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology 58:615-620
9. Van den Berg-Vos RM, Franssen H, Wokke JHJ, Van Es HV, Van den Berg LH (2000) Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin. Neurology 48:919-926
10. Carpo M, Allaria S, Scarlato G, Nobile-Orazio E (1999) Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy. Neurology 53:2206-2207
11. Pestronk A, Choksi R (1997) Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 49: 289-1292
12. van Schaik IN, Bossuyt PMM, Brand A, Vermeulen M (1995) Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta analysis. Neurology 45:1570-1577
13. Kaji R, Nobuyuki O, Tsuji T, Mezaki T, Nishio T, Akiguchi I, Kimura J (1993) Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 33:152-158
14. Van Es HW, Van den Berg LH, Franssen H, Witkamp TD, Ramos LMP, Notermans NC, Feldberg MAM, Wokke JHJ (1997) Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 48:1218-1224
15. Donaghy M, Mills KR, Boniface SJ, Simmons J, Wright I, Gregson N, Jacobs J (1994) Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 57:778-783
16. Carpo M, Cappellari A, Mora G, Pedotti R, Barbieri S, Scarlato G, Nobile-Orazio E (1998) Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 50:1480-1482
17. Azulay J-P, Blin O, Pouget J, Boucraut J, Billé-Turc F, Carles G, Serratrice G (1994) Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies. Neurology 44:429-432
18. Van den Berg LH, Kerkhoff H, Oey PL, Franssen H, Mollee I, Vermeulen M, Jennekens FGI, Wokke JHJ (1995) Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 59:248-252
19. Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE (2000) Multifocal motor neuropathy improved by IVIg. Randomized, double-blind, placebo-controlled, study. Neurology 55:1257-1262
20. Léger J-M, Chassande B, Musset L, Meininger V, Bouche P, Bauman N (2001) Intravenous immunoglobulin therapy in multilocal motor neuropathy: a double-blind placebo-controlled study. Brain 124:145-153
21. Azulay J-P, Rihet P, Pouget J, Cador F, Blin O, Boucraut J, Serratrice G (1997) Long-term follow-up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry 62:391-394
22. Van den Berg-Vos RM, Franssen H, Wokke JHJ, Van den Berg LH (2002) Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain 125:1875-1886
23. Meucci N, Cappellari A, Barbieri S, Scarlato G, Nobile-Orazio E (1997). Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 63:765-769
24. Umapathi T, Hughes RAC, Nobile-Orazio E, Leger JM (2002). Immunosuppressive treatment for multifocal motor neuropathy. The Cochrane library, Issue 3. Update Software, Oxford
25. Brannagan TH, Nagle KJ, Lange DJ, Rowland LP (1996) Complications of intravenous immunoglobulin treatment in neurologic disease. Neurology 47:674-677
26. Stangel M, Hartung H-P, Marx P, Gold R (1998) Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci 153,203-214
27. Malik U, Oleksowicz L, Latov N, Cardo LJ (1996) Intravenous γ-Globulin inhibits binding of anti-GM1 on its target antigen. Ann Neurol 39:136-139